The Influence of Natural Killer Cells in Neuroblastoma
- 1 February 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 124 (2) , 235-239
- https://doi.org/10.1001/archsurg.1989.01410020109018
Abstract
• Human neuroblastoma (NRB) cell lines are markedly sensitive to natural killer (NK) cell lysis in vitro, but patients with NRBs have low or absent NK activity. This study evaluated the NK sensitivity of murine NRBs (C1300 and TBJ) in the regulation of NRB growth and determined the effects of recombinant (r) interferon gamma and recombinant interleukin 2 (rIL-2). Both basal (8%±3% specific cytotoxicity) and induced (20%±3%) NK lyses of C1300-NRB were observed. In vivo depletion of NK cells with anti–asialo GM-1 significantly enhanced growth of C1300-NRB and deceased survival. Treatment wth r–interferon gamma or rIL-2 on days 1 through 3 after C1300-NRB inoculation significantly prolonged the mean tumor latency period, decreased the tumor growth rate, and enhanced in vitro NK killing of C1300-NRB and YAC-1. The effects of R–interferon gamma and IL-2 were abrogated by pretreatment with anti–asialo GM-1. These results demonstrated that NK cells form one important component of regulation of a murine NRB, but immunomodulation with potent lymphokines requires cooperation of more than one cell type. (Arch Surg 1989;124:235-239)Keywords
This publication has 6 references indexed in Scilit:
- Cancers of ChildhoodPublished by Springer Publishing Company ,2017
- Natural killer activity: the definition of a function rather than a cell typeImmunology Today, 1987
- Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon.Proceedings of the National Academy of Sciences, 1984
- Immune aspects of neuroblastomaThe American Journal of Surgery, 1971
- SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSISThe Lancet, 1971
- Accurate Identification of Experimental Pulmonary Metastases2JNCI Journal of the National Cancer Institute, 1966